Article
Different Immunotherapeutic Combinations Enhance Specific T Cell Immune Responses Against Leukemic Cells, as well as Leukemic Progenitor and Stem Cells, in Acute Myeloid Leukemia
2025-06-18
Abstract excerpt
<title>Abstract</title> <p> Immunotherapeutic approaches have become increasingly important in cancer therapy, including for patients with acute myeloid leukaemia (AML). Despite being shown to be effective in the context of stem cell transplants for almost 50 years, further improvements are required to prevent relapse and its associated morbidity. The therapeutic use of immune checkpoint inhibition in AML is sti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 18221b55-af50-5e17-bd7c-05cb2543cb1c
- DOI
- 10.21203/rs.3.rs-6523399/v1
